<DOC>
	<DOC>NCT01105013</DOC>
	<brief_summary>This is a study clinical, multicenter, Phase III trial, to evaluate the efficacy and safety of tolnaftate cream in the treatment of patients with fungal infections such as Tinea foot, Tinea and Tinea crural body.</brief_summary>
	<brief_title>Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections</brief_title>
	<detailed_description>Study Clinical, multicenter, Phase III, to evaluate the efficacy and safety of 10mg/g tolnaftate cream in the treatment of patients with fungal infections such as Tinea foot, Tinea and Tinea crural body.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<mesh_term>Tolnaftate</mesh_term>
	<criteria>Patients of both sexes, of any race, aged 12 years; Ability to understand and sign the IC (for patients older than age) in the case of minors monitoring and consent of a guardian; Clinical diagnosis of fungal infections for tinea pedis (ringworm of the feet) or tinea cruris (ringworm of the groin region), or tinea corporis (ringworm in other body areas); Direct mycological exam positive for fungi; Pregnant women or nursing mothers; Use of topical or oral antifungal; Use of steroids; Allergy or hypersensitivity to any component of product; Clinical cases of tinea infection by bacteria and / or eczema, tinea extensive and onychomycosis.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>fungal infections</keyword>
	<keyword>tinea</keyword>
	<keyword>tonaftato</keyword>
</DOC>